WASHINGTON D.C. — The U.S. Department of Health and Human Services (HHS) commenced widespread staff reductions on Tuesday, April 1, 2025, marking the beginning of a significant overhaul aimed at downsizing the federal agencies tasked with safeguarding and advancing the health of Americans. Employees across various disciplines within the department, including vital roles such as researchers, scientists, medical doctors, essential support staff, and even senior leadership figures, were informed of their job eliminations through emailed notices.
Understanding the Scope of the Overhaul
This large-scale restructuring plan, initially announced last week, seeks to shrink the overall workforce of the Health and Human Services Department to approximately 62,000 positions. This target represents a reduction of nearly a quarter of its staff, with a total of 20,000 jobs slated for elimination. The cuts are planned to be achieved through a combination of methods: approximately 10,000 positions are being eliminated via direct layoffs, while another 10,000 are expected to be reduced through offers of early retirement and voluntary separation packages.
HHS officials project that these workforce reductions will yield annual savings of approximately $1.8 billion. While a substantial sum, this figure represents a small fraction of the department’s vast $1.7 trillion budget, the majority of which is dedicated to funding critical social safety net programs like Medicare and Medicaid.
New Leadership Takes Helm Amidst Cuts
The commencement of these job cuts coincided with significant leadership changes within key HHS components. Health Secretary Robert F. Kennedy Jr. presided over the swearing-in ceremony for new appointees, including Dr. Jay Bhattacharya, who is taking the helm as the new director of the National Institutes of Health (NIH), and Martin Makary, who has been appointed as the new commissioner of the Food and Drug Administration (FDA).
Speaking at the ceremony, Secretary Kennedy Jr. declared, “The revolution begins today!” He later expanded on the administration’s vision for the department, stating that HHS needs to be “recalibrated” with a renewed emphasis on disease prevention as a core focus.
Agency-Specific Impacts Detailed
The impact of the workforce reduction is being felt across various critical federal health agencies housed within HHS.
At the National Institutes of Health (NIH), the nation’s premier biomedical research agency, approximately 1,200 jobs are being eliminated in this latest round of cuts. This follows previous significant reductions during the Trump administration, which saw over 1,000 NIH employees fired and hundreds of research grants canceled, raising concerns among the scientific community about the future of federal health research.
The Food and Drug Administration (FDA), responsible for ensuring the safety and efficacy of drugs, medical devices, and the food supply, is facing even deeper cuts, set to lose a substantial 3,500 staffers. These reductions are expected to impact critical functions, including the rigorous process of reviewing new drugs and medical implants before they reach the public. The cuts also affect teams responsible for setting e-cigarette and tobacco policy. In a move that drew particular attention, the agency’s entire press office was eliminated, and its top tobacco regulator was also removed from their position.
The Centers for Medicare & Medicaid Services (CMS), which oversees the Affordable Care Act as well as the vast Medicare and Medicaid programs providing health coverage to millions of Americans, is scheduled to cut around 300 jobs.
Meanwhile, the Centers for Disease Control and Prevention (CDC), the nation’s leading public health agency focused on preventing and responding to disease outbreaks and health threats, is seeing the outright elimination of several specific public health programs. These include initiatives focused on critical areas such as smoking cessation, lead poisoning prevention, gun violence research and prevention, asthma management, air quality monitoring, and occupational safety and health. Additionally, the CDC’s entire Freedom of Information Act (FOIA) office, responsible for public transparency regarding the agency’s activities, has been shuttered. At least nine high-level CDC directors were reportedly placed on administrative leave and have been offered reassignments to positions within the Indian Health Service.
Broader Context and Growing Legal Challenges
These significant workforce reductions at HHS headquarters and its constituent agencies follow a separate but related action taken by the department just last week: the withdrawal of over $11 billion in funding previously allocated for COVID-19-related initiatives. This withdrawal of funds has also reportedly led to corresponding cuts at state and local health departments across the nation, which rely heavily on federal pass-through funding to operate many of their public health programs.
The rapid and extensive nature of these changes has already drawn legal challenges. Reports indicate that nineteen U.S. states are reportedly suing the federal government over the cuts impacting the U.S. Health and Human Services agency, arguing that the actions could undermine public health infrastructure and services.
Outlook and Implications
The sweeping overhaul and mass layoffs at the U.S. Department of Health and Human Services represent a profound shift in the structure and stated priorities of the federal health apparatus. While proponents argue the changes are necessary for efficiency and a refocused mission on prevention, critics express serious concerns about the potential long-term impact on the nation’s ability to conduct critical research, regulate essential products, respond to health crises, and provide foundational public health services to the American population.
